These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25380620)
1. Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays. Jung K; Wang P; Gupta N; Gopal K; Wu F; Ye X; Alshareef A; Bigras G; McMullen TP; Abdulkarim BS; Lai R Breast Cancer Res; 2014 Nov; 16(6):470. PubMed ID: 25380620 [TBL] [Abstract][Full Text] [Related]
2. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells. Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403 [TBL] [Abstract][Full Text] [Related]
3. DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer. Alqahtani H; Gopal K; Gupta N; Jung K; Alshareef A; Ye X; Wu F; Li L; Lai R Cell Signal; 2016 Feb; 28(2):42-50. PubMed ID: 26569340 [TBL] [Abstract][Full Text] [Related]
4. Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporter. Gopal K; Gupta N; Zhang H; Alshareef A; Alqahtani H; Bigras G; Lewis J; Douglas D; Kneteman N; Lavasanifar A; Lai R Oncotarget; 2016 Jan; 7(3):3111-27. PubMed ID: 26683522 [TBL] [Abstract][Full Text] [Related]
5. Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity. Wu F; Ye X; Wang P; Jung K; Wu C; Douglas D; Kneteman N; Bigras G; Ma Y; Lai R BMC Cancer; 2013 Jul; 13():317. PubMed ID: 23815808 [TBL] [Abstract][Full Text] [Related]
6. β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells. Ye X; Wu F; Wu C; Wang P; Jung K; Gopal K; Ma Y; Li L; Lai R Cell Signal; 2014 Mar; 26(3):492-501. PubMed ID: 24291232 [TBL] [Abstract][Full Text] [Related]
7. Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity. Wu F; Zhang J; Wang P; Ye X; Jung K; Bone KM; Pearson JD; Ingham RJ; McMullen TP; Ma Y; Lai R Cell Signal; 2012 Nov; 24(11):1989-98. PubMed ID: 22800865 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Iida H; Suzuki M; Goitsuka R; Ueno H Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321 [TBL] [Abstract][Full Text] [Related]
9. A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma. Wu C; Zhang HF; Gupta N; Alshareef A; Wang Q; Huang YH; Lewis JT; Douglas DN; Kneteman NM; Lai R J Hematol Oncol; 2016 Nov; 9(1):120. PubMed ID: 27821172 [TBL] [Abstract][Full Text] [Related]
10. Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability. Lee JY; Lee SH; Heo SH; Kim KS; Kim C; Kim DK; Ko JJ; Park KS PLoS One; 2015; 10(10):e0141118. PubMed ID: 26492085 [TBL] [Abstract][Full Text] [Related]
11. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression. Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817 [TBL] [Abstract][Full Text] [Related]
12. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma. Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590 [TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of human breast cancer cells with SOX2 promoter activity. Liang S; Furuhashi M; Nakane R; Nakazawa S; Goudarzi H; Hamada J; Iizasa H Biochem Biophys Res Commun; 2013 Jul; 437(2):205-11. PubMed ID: 23796710 [TBL] [Abstract][Full Text] [Related]
14. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes. He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314 [TBL] [Abstract][Full Text] [Related]
15. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699 [TBL] [Abstract][Full Text] [Related]
16. Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter. Jung K; Gupta N; Wang P; Lewis JT; Gopal K; Wu F; Ye X; Alshareef A; Abdulkarim BS; Douglas DN; Kneteman NM; Lai R Oncotarget; 2015 Apr; 6(12):10366-73. PubMed ID: 25868977 [TBL] [Abstract][Full Text] [Related]
17. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors. Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631 [TBL] [Abstract][Full Text] [Related]
18. SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells. Jin ML; Yang L; Jeong KW Theranostics; 2022; 12(13):5761-5775. PubMed ID: 35966598 [No Abstract] [Full Text] [Related]
19. Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features. Gupta N; Gopal K; Wu C; Alshareef A; Chow A; Wu F; Wang P; Ye X; Bigras G; Lai R Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29401647 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Zhao C; Gao H; Liu Y; Papoutsi Z; Jaffrey S; Gustafsson JA; Dahlman-Wright K Cancer Res; 2010 Jun; 70(12):5174-83. PubMed ID: 20501845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]